ADVERTISEMENT

Divi's Labs Q2 Results Review - Pricing Pressure In API Segment Hurts Profitability: Motilal Oswal

Custom synthesis segment sales to pick up pace in the coming quarters

<div class="paragraphs"><p>Drug pills. (Source: Unsplash)</p></div>
Drug pills. (Source: Unsplash)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit